The COA included endotoxin and sterility data which our lab requires. Both batches came well within TFA acceptable limits
The delayed-release capsule is designed to deliver this higher-potency dose to the lower gastrointestinal region, supporting tissue integrity, digestive balance, and whole-body resilience
The most commonly reported adverse reactions were hypersensitivity reactions (e.g., rash, urticaria), edema-related reactions (e.g., arthralgia, extremity pain, peripheral edema, and carpal tunnel syndrome), hyperglycemia, and injection site reactions (injection site erythema, pruritus, pain, urticaria, irritation, swelling, and hemorrhage)
The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs